The European Research Council (ERC) has announced that we got the Proof of Concept grant to continue developing our needle-free injector prototype!
We want to revolutionize the experience of people who receive or perform frequent injections by developing a portable needle-free device using lasers and microjets.
Bold-Jet will become a solution perfectly suitable for treatments that do not require a high dosage in one injection event. Among others, vaccines such as antigen-based and nanoparticle-based (as used for mRNA vaccines against COVID-19), hormones, and drugs with elevated potency are good candidates. The same technology will be capable of injecting other types of liquids of great commercial relevance, such as inks and cosmetic formulations.